Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7280574 | Brain, Behavior, and Immunity | 2016 | 14 Pages |
Abstract
Taken together, these results suggest that beneficial effects of FTY720 in neonatal oxygen-induced brain injury may be rather attributed to its anti-oxidative and anti-inflammatory capacity acting in concert with a direct protection of developing oligodendrocytes than to a modulation of peripheral lymphocyte trafficking. Thus, FTY720 might be a potential new therapeutic option for the treatment of neonatal brain injury through reduction of white matter damage.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Meray Serdar, Josephine Herz, Karina Kempe, Katharina Lumpe, Barbara S. Reinboth, Stéphane V. Sizonenko, Xinlin Hou, Ralf Herrmann, Martin Hadamitzky, Rolf Heumann, Wiebke Hansen, Marco Sifringer, Yohan van de Looij, Ursula Felderhoff-Müser,